IBL/流感嗜血杆菌B(HIB)IgG ELISA/RE56351/
市场价:
¥0.00
美元价:
0.00
产品分类:
夹心法ELISA
公司分类:
Sandwich_method_ELISA
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Kitsize | 12x8 |
Method | ELISA |
Incubationtime | 2x1h,1x30min |
Standardrange | Lotspecific |
Specimen/Volumes | 20µlSerum,Plasma |
Substrate/isotope | TMB450nm |
RegulatoryStatus: | EU:CE,CDN:IVD |
Detailsfor: HaemophilusinfluenzaeB(HIB)IgGELISA
HaemophilusinfluenzaetypeB(HiB)isaverycommoncauseofinvasivecriticalinfectiousdiseasesinchildrenuptotheageofsix.Followinginfectionthesymptomsofthediseaseinclude:Pericarditis,osteomyelitis,meningitis,encephalitis,pneumonia,sinusitisandotitis.Inmanycasesthediseaseislethalorleadstoneurologicaldamage,whichcannotalwaysbepreventedbyrapidantibiotictherapy.Theunderlyingreasonforthediseaseisveryoftenalatentimmunodeficiencywithaspecificallyreducedhumoralimmuneresponsetothepolyribosylribitolphosphate(PRP)inthepolysaccharideencapsulationofthebacterium.Inchildrenanotherreasonistheimmaturityoftheimmunesystem.Todayoftentheterm"immunocompromisedpatients"isused,comprisingallacquiredandinnatespecificandunspecificimmunodeficiencies.
Asaresult,inchildrenof3monthsofageorolderavaccinationwithdifferentsortsofPRP-containingvaccinesisrecommended.ThiscanleadtoaclearreductioninthenumberofinfectionswithHaemophilusinfluenzaetypeB.
Thetiterofantibodiesproducedbyvaccinationcanbeusedtoconfirmwhetherthevaccinationhasbeensuccessful.TheHiBIgGisusedtomeasurethelevelofPRP-specificIgG-antibodiesfollowinga46weekperiodaftercompleteimmunizationtomonitorthehumoralimmunestatusofchildrenorotherindividualsatrisk.
Monitoringofthehumoralimmunostatusaftervaccination.VerificationofthediagnosisHaemophilusinfluenzaetypeBinfectionbyrepeatedmonitoringofantibodyconcentrations.RiskassessmentinimmunocompromisedpatientsleADIngtoafailureofvaccinationwithaPRP-containingvaccine.
Thisgroupcomprises:
Childrenunder2yearshavinghadaninfectionwithHaemophilusinfluenzaetypeB,
Childrenwithchronic,recurringbacterialinfectionsoftherespiratorytract,
Childrenwithchronicotitis,
Patientswithconfirmedhumoralimmuno-deficiencies(IgG-2-deficiency,IgA-deficiency),
Patientswithconfirmedgranulocytedeficiencies,
Patientsunderchemoorcytostatictherapy,
Childrenaftersplenectomy,
Patientswithsickle-cellanaemia,
Patientswithtrisomy21(Down)syndrome,andcertainethnicgroups.
ForconcretedatapleaseconsulttheInstructionforUseinthedownloadboxontherightside.Asaresult,inchildrenof3monthsofageorolderavaccinationwithdifferentsortsofPRP-containingvaccinesisrecommended.ThiscanleadtoaclearreductioninthenumberofinfectionswithHaemophilusinfluenzaetypeB.
Thetiterofantibodiesproducedbyvaccinationcanbeusedtoconfirmwhetherthevaccinationhasbeensuccessful.TheHiBIgGisusedtomeasurethelevelofPRP-specificIgG-antibodiesfollowinga46weekperiodaftercompleteimmunizationtomonitorthehumoralimmunestatusofchildrenorotherindividualsatrisk.
Monitoringofthehumoralimmunostatusaftervaccination.VerificationofthediagnosisHaemophilusinfluenzaetypeBinfectionbyrepeatedmonitoringofantibodyconcentrations.RiskassessmentinimmunocompromisedpatientsleADIngtoafailureofvaccinationwithaPRP-containingvaccine.
Thisgroupcomprises:
Childrenunder2yearshavinghadaninfectionwithHaemophilusinfluenzaetypeB,
Childrenwithchronic,recurringbacterialinfectionsoftherespiratorytract,
Childrenwithchronicotitis,
Patientswithconfirmedhumoralimmuno-deficiencies(IgG-2-deficiency,IgA-deficiency),
Patientswithconfirmedgranulocytedeficiencies,
Patientsunderchemoorcytostatictherapy,
Childrenaftersplenectomy,
Patientswithsickle-cellanaemia,
Patientswithtrisomy21(Down)syndrome,andcertainethnicgroups.
品牌介绍
IBL我们的愿景是通过Tecan技术,产品和支持,为世界各地的每个实验室提供支持。我们旨在通过无与伦比的专业知识,产品和客户支持来塑造生命科学和临床诊断自动化工作流程的未来。